Clinical Trials on IPSS Risk Category Intermediate-1 in Italy
Total 7 results
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...University of Milan; Italian Air Force; A-Tono; Ministry of Defense, ItalyRecruitingCardiovascular Risk Factor | Discogenic Pain | Neuroplasticity | Epigenetic Changes | Stress Physiological | Space Maintenance | Oxidative Injury | LONGEVITY 1 | NGSItaly
-
Hendrik StreeckJanssen, LPCompletedHIV Infections | Sexual Behavior | HIV-1-infection | Risk ReductionFrance, Hungary, Spain, Poland, Italy
-
European Institute of OncologyRecruitingAnal Cancer | High-Risk Cancer | Anal Intraepithelial Neoplasia 2 | Anal Intraepithelial Neoplasia 1Italy
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria